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The binary, ternary, quaternary, and quintary interactions of a five-component mixture of
carcinogenic environmental polycyclic aromatic hydrocarbons (PAHs) using response surface
analyses are described. Initially, lung tumor dose-response curves in strain ANJ mice for each of
the individual PAHs benzo[alpyrene (B[a]P), benzo[blfluoranthene (B[b]F), dibenz[a,hlanthracene
(DBA), 5-methylchrysene (5MC), and cyclopenta[cdlpyrene (CPP) were obtained. From these
data, doses were selected for the quintary mixture study based on toxicity, survival, range of
response, and predicted tumor yields. The ratios of doses among PAHs were designed to
simulate PAH ratios found in environmental air and combustion samples. Quintary mixtures of
B[aIP, B[bIF, DBA, 5MC, and CPP were administered to male strain A/J mice in a 25 factorial 32-
dose group dosing scheme (combinations of five PAHs each at either high or low doses) and lung
adenomas were scored. Comparison of observed lung adenoma formation with that expected
from additivity identified both greater than additive and less than additive interactions that were
dose related i.e., greater than additive at lower doses and less than additive at higher doses. To
identify specific interactions, a response surface analysis using response addition was applied to
the tumor data. This response surface model contained five dose, ten binary, ten ternary, five
quaternary, and one quintary parameter. This analysis produced statistically significant values for
16 parameters. The model and model parameters were evaluated by estimating the
dose-response relationships for each of the five PAHs. The predicted dose-response curves for
all five PAHs indicated a good estimation. The binary interaction functions were dominated for the
most part by DBA and were inhibitory. The response surface model predicted, to a significant
degree, the observed lung tumorigenic responses of the quintary mixtures. These data suggest
that although interactions between PAHs do occur, they are limited in extent. - Environ Health
Perspect 106(Suppl 6):1337-1346 (1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-6/
1337-1346nesnow/abstract.html
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The interactions ofmixtures ofchemicals in
biologic systems have been studied exten-
sively in pharmacology (1,2) and toxicology
(3). In general, these interactions can be
classified as enhancing (greater than
additive), inhibitory (less than additive), or
no interaction (additive). When adminis-
tered to experimental animals, chemical
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carcinogens exhibit all three ofthese effects
depending on the chemicals, route of
administration, sex, species, and target
organ. The majority of these interaction
studies have been performed using only
two administered agents and a database of
binary carcinogen interactions has been
reported (4,5).
Polycyclic aromatic hydrocarbons
(PAHs) are a pervasive class ofenvironmen-
tal pollutant formed by the incomplete
combustion oforganic materials. Humans
are exposed to PAHs from cigarette smoke,
combustion products from gasoline, diesel
fuel, coal, and oil, as well as from broiled
and smoked foods (6). Many PAHs are
carcinogenic in experimental animals and
several PAH-containing mixtures (i.e.,
coke oven emissions, cigarette smoke, and
coal tars) are human carcinogens (7-9).
Although there have been a number of
studies of interactions of PAHs within
binary mixtures of PAHs, little work has
focused on larger component mixtures and
using lung tissues as tumor targets.
We selected five environmental PAHs
to construct quintary (five-component)
mixtures to examine tumorigenic inter-
actions among PAHs. The PAHs benzo[a]
pyrene (B[a]P), benzo[b]fluoranthene
(B[b]F), dibenz[a,h]anthracene (DBA), 5-
methylchrysene (5MC), and cyclopenta-
[cd]pyrene (CPP) were selected for the
extent and pervasiveness of their environ-
mental occurrence, structural diversity,
metabolic diversity, and range of tumori-
genic potency. Using the strain A/lJ mouse
lung as a target organ, we sought to answer
the following questions: Are the mouse
lung tumorigenic activities of these five
PAHs additive? What is the extent of the
deviation from additivity? Can specific
interaction parameters be calculated? What
is the effect of a nontumorigenic PAH on
the tumorigenic activity of a quintary
mixture ofPAHs?
Methods for analysis of interactions
have been reviewed including isobolo-
graphic analyses (10), interaction indexes
(11), and response surface approaches (12).
Response surface approaches have found
use in identifying and quantitating chemi-
cal and drug interactions (13-16). Resp-
onse surface methods use regression
techniques that are both descriptive and
predictive and are not limited to number of
independent variables or same mechanisms
of action or dose-response slopes. We
utilized a response surface methodology,
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using response addition, to both design and
analyze a study that sought to identify and
quantitate the interactions among five envi-
ronmental PAH lung tumorigens. Using a
25 factorial experimental design (five PAHs
at two doses each) strain A/J mice were
treated with a series ofquintary PAH mix-
tures and lung adenomas were enumerated
after 8 months.
We report that PAH-induced lung
adenoma formation in strain A/J mice
can exhibit both greater than additive and
less than additive interactions that are
dose related. Interaction analyses by
maximum likelihood methods using a
response surface model identified statis-
tically significant binary, ternary, and
quaternary interactions.
Materials and Methods
Chemicals
B[b]F (99%), DBA (97%), urethane
(99%), and pyrene were purchased from
Aldrich Chemical Co. (Milwaukee, Wis-
consin) and B[a]P(298%) from Sigma
Chemical Co. (St. Louis, Missouri). CPP
(99%) was obtained from A. Gold
(University of North Carolina, Chapel
Hill, North Carolina) and 5MC (99%)
from S. Amin (American Health Found-
ation, Valhalla, New York). Tricaprylin
was purchased from Eastman Kodak
(Rochester, New York). The crude pyrene
was purified by column chromatography in
hexane using silica gel, recrystallized from
hexane, and sublimed in vacuo at 170°C to
give a melting point of 149 to 151°C. The
reported melting point was 149.6 to
150.3°C (17). Liquid chromatography-
mass spectrometry indicated this product
was 99.7% pure.
TumorStudies
Male strain A/J mice 6 to 8 weeks of age
were obtained from Jackson Laboratories
(Bar Harbor, Maine). Mice were housed
in laminar flow rooms in groups of four
in polycarbonate cages. Mice were main-
tained under standard conditions
(20 ±2°C; 50 ± 10% relative humidity;
12-hr light/dark cycle) and received food
and water ad libitum. In the first study,
individual PAHs were administered to
male strain A/J mice at several doses. On
the day of treatment, PAHs were soni-
cated in tricaprylin until complete solu-
tion was achieved, then mice were
injected ip (0.2 ml/mouse). Urethane-
and tricaprylin-treated mice served as pos-
itive and negative controls, respectively.
After 8 months, all mice were sacrificed
by cervical dislocation, the lungs removed,
fixed in 10% neutral buffered formalin,
and the surface tumors counted. No
detailed histopathology was performed, as
previous studies have identified these
lesions as adenomas (18). In the second
study (mixture study), a 25 factorial
experimental design (five agents each at
two doses) was used. Thirty-two groups of
mice were randomized (20 per group) and
dosing was performed in the order of the
randomized group number. PAH mix-
tures were prepared by transferring indi-
vidually weighed PAHs into each of 32
vials to construct the 32 dosing vials of
quintary mixtures ofPAHs. Quality assur-
ance analysis by HPLC verified that the
target doses were achieved (data not
shown). Animals were treated and tumors
were scored as described previously. In the
second study smaller numbers of animals
(10 mice per dose) were treated with the
high dose of each PAH as indicator
controls. Animal care and treatment were
conducted in accordance with the
guidelines established in the Guidefor the
Care and Use ofLaboratory Animals (19).
All animals were treated humanelywith due
consideration to the alleviation ofdistress
and discomfort.
Staistics
Normality was examined by the
Kolmogorov-Smirnov test, multiple
comparisons by the Bonferroni multiple
comparison test or Students-Newman-
Kuels multiple comparison test (Sigma-
Stat, Jandel Scientific, San Rafael,
California), log likelihood analysis by SAS
(SAS Institute, Cary, North Carolina),
and multiple linear regression analysis
using Mathematica (Wolfram Research,
Champaign, Illinois).
Results
DoseResponses ofIndividual
PolycycicAromaticHydrocarbons
Dose-response studies were performed
with each of the five PAHs at dose ranges
that resulted in a survival of 75 to 100%
(Table 1). Statistical analysis indicated
that 15 ofthe 22 groups were significantly
different (p< 0.01) from the tricaprylin
control group using a Bonferroni multiple
comparison test on the square root trans-
formed tumor response data. Both posi-
tive (urethane) and vehicle (tricaprylin)
controls for lung adenoma response were
in agreement with historical data (18).
Selecting DoseLevels forQuintary
Mixtures ofPolycyclicAromatic
Hydrocarbons
Dose levels were selected that would satisfy
the following: < 25% mortality; < 10%
reduction in weight gain at the end of the
study; a predicted range oftumor response
between 2 and 100 lung adenomas per
mouse; and the ability to observe an over-
all 2-fold greater than additive and a
4-fold less than additive tumor response.
In addition, the PAH dose levels were
prepared in ratios similar to those found
in environmental air and combustion
samples. In cigarette smoke (9), coal
gasification emissions (21), ambient air
(22), coke oven emissions (23), gasoline
exhaust, and diesel exhaust (24), B[b]F
and B[a]P are found in approximately
equal amounts. In ambient air (22), diesel
exhaust (24), and coke oven emissions
(25), DBA is found in amounts that are
approximately 5 to 40% that of B[b]F or
B[a]P. CPP environmental levels range
from 250 to 2000% of that of B[b]F or
B[a]P in ambient air (22), gasoline
exhaust, and diesel exhaust (24). 5MC has
been detected in gasoline exhaust at
approximately 6 to 10% that of B[b]F or
B[a]P (24). Therefore, based on the dose-
response data in Table 1 and the environ-
mental levels discussed previously, the fol-
lowing dose levels in milligrams per
kilogram were selected (high dose/low
dose): B[a]P, 75/30; B[b]F, 75/30; DBA,
10/2.5; 5MC, 30/10; and CPP 100/30.
The dosing groups were selected according
to a 25 factorial dosing scheme (12,13).
This resulted in 32 PAH mixture groups
representing combinations offive PAHs at
either high or low dose (Table 2). This
dose scheme would allow the calculation of
five PAH dose parameters, ten binary
interaction parameters, ten ternary interac-
tion parameters, five quaternary interaction
parameters, and one quintary parameter.
Analyses ofPolycyclicAromatic
HydrocarbonMixtueTumorData
Survival of mice in the 32 PAH mixture
groups ranged from 70 to 100%, with a
median of 85% and a mean (± SD) of
84.8 ±9.1 (Table 2). No dose dependency
could be established between survival and
doses of PAHs with the dose range tested.
The mean body weights for the highest
dosed group compared to tricaprylin
control indicated a significant loss of
weight at day 7 with a recovery to control
values on day 14 and beyond (data not
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Table 1. Lung tumorigenic responses of male strain A/J mice exposed to individual PAHs.a
No. Mice Mean observed
Dose, mg/kg mice treated/ surviving, lung adenomas
B[a]P B[b]F DBA 5MC CPP mice scored % per mouse Variance
5 0 0 0 0 20/20 100 0.45 0.682
10 0 0 0 0 20/17 85 0.529 0.640
50 0 0 0 0 20/19 95 4.37b,* 7.91
100 0 0 0 0 20/16 80 12.71 * 19.5
200 0 0 0 0 24/24 100 33.0b.* 109
0 10 0 0 0 20/18 90 0.670 0.588
0 50 0 0 0 20/20 100 2.00* 3.47
0 100 0 0 0 20/20 100 5.30b,* 10.9
0 200 0 0 0 20/19 95 6.95b,* 13.1
0 0 1.25 0 0 20/18 90 1.44 2.26
0 0 2.5 0 0 20/19 95 3.05* 3.83
0 0 5.0 0 0 20/20 100 13.1b,* 37.7
0 0 10 0 0 20/19 95 32.1b,* 123
0 0 0 10 0 20/20 100 1.75 2.62
0 0 0 50 0 20/18 90 39.0b,* 187
0 0 0 100 0 20/15 75 93.1b,* 399
0 0 0 0 10 20/20 100 0.55 0.682
0 0 0 0 50 20/20 100 4.75b,* 4.72
0 0 0 0 100 20/19 95 32.2b,* 242
0 0 0 0 200 20/18 90 1103b,* 350
Oc 0 0 0 0 20/20 100 0.60 0.358
Urethane 1000 - - - 20/16 80 28.1b,* 25.9
aMice were treated with each PAH dissolved in tricaprylin by single ip injection (0.2 ml) and tumors scored 8 months later. These data have been reported in earlier publica-
tions and are reproduced forcomparison to the response surface model results [(20) and references therein]. bThis group exhibited a 100% tumor incidence. clricaprylin vehi-
cle control. *Significantly different at p<0.01 from the tricaprylin control by the Bonferroni multiple comparison test after a square root transformation of each data point.
Values in bold text are statistically significant.
shown). The mean body weights for each
group at sacrifice were indistinguishable
from that of the tricaprylin control group
(data not shown).
The 32 PAH mixture groups gave
tumor responses that ranged from 16.8 to
63.8 lung adenomas per mouse (Table 2).
Statistical analysis using the Kolmogorov-
Smirnov test on the numbers of tumors per
mouse for each group indicated that many
groups were not normally distributed, a
conclusion supported by the observation
that the variances exceeded the means for
many groups. Statistical comparison indi-
cated that each group was significantly dif-
ferent (p < 0.01) from the tricaprylin control
group using a Bonferroni multiple compari-
son test on the square root transformed
tumor response data.
Comparison ofObserved Responses
to those Predicted Based onAdditive
Responses from Individual Polycylic
AromaticHydrocarbon
Dose-Response Data
The expected additive responses for each
PAH mixture were calculated by summing
the responses from individual PAHs that
comprised each mixture, using data from
Table 1. Tumor responses for intermediate
doses not specifically tested were obtained
by estimates derived using curve-fitting
procedures from a power equation as
described in Nesnow et al. (20). The
relationship between the observed lung
adenomas per mouse and the expected lung
adenomas per mouse based on additive
responses for each of the 32 PAH mixture
groups indicated that many ofthe observed
data points deviated from those expected
based on additivity (Figure 1). Two groups
exhibited a statistically significant increase
in expected tumor responses and 13 groups
exhibited a significant decrease (p<0.05) by
the Students-Newman-Keuls multiple com-
parison test on the square root transformed
data. Regressing the data to a linear func-
tion (R2 =0.679) gave major deviations
from the expected slope ofunity (calculated
slope = 1.70) and the expectedy-intercept of
zero (calculated y-intercept =-13.53). Cal-
culation ofthe percent increase or decrease
of observed tumor responses over the
expected tumor responses based on additiv-
ity {100 x[(observed additivity)/additivity]}
gave a range of 97.4% superadditivity to
55% supraadditivity.
Estimation oftheResponse
SurfceModel
A generalized linear model (26) was fit to
the data parameterized according to
Equation 1 (Appendix). The variance of
the response was assumed to be ofthe form
0,u (i.e., a constant times the mean). The
method of maximum likelihood was used
to estimate the unknown model parameters
using a ridge-stabilized Newton-Raphson
algorithm (PROc GENMOD, SAS version
6.09). A power link function was used for
g(,u) in Equation 1 with the best power
estimate determined from a plot ofthe log
likelihood versus the power parameter
(Figure 2). The peak of this plot was
approximately 0.5. Therefore, the square
root transformation of the response data
(lung adenomas per mouse) was used in
the subsequent analysis of the data. To
determine the shapes ofthe dose-response
curves using the square root transformation
for each individual PAH, the tumor data in
Table 1 was square root transformed and
plotted against dose (data not shown).
Each PAH yielded a linear relationship
with correlation coefficients >0.90, adding
support for the use of a square root-linear
equation to describe the mixture data in
the response surfaceanalyses.
ResponseSurfceAnalyses
A square root-linear equation (Equation
1) was used to describe the 32-group
quintary PAH mixture data. The equation
contained 5 dose parameters and 26 inter-
action parameters: 10 binary, 10 ternary,
5 quaternary, and 1 quintary. A regression
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Table 2. Lung tumorigenic responses of male strain A/J mice exposed to quintary mixtures of polycyclic aromatic hydrocarbons.a
No. Mice Mean observed
Dose, mg/kg micetreated/ surviving, lung adenomas
B[a]P B[b]F DBA 5MC CPP mice scored % per mouse Variance
30 30 2.5 10 30 20/15 75 18.7* 158
75 30 2.5 10 30 20/17 85 26.7* 163
30 75 2.5 10 30 20/20 100 16.8* 82.0
30 30 10 10 30 20/18 90 26.2* 107
30 30 2.5 30 30 20/20 100 29.5* 67.9
30 30 2.5 10 100 20/16 80 31.8* 242
75 75 2.5 10 30 20/18 90 20.6* 50.4
75 30 10 10 30 20/16 80 36.4* 199
75 30 2.5 30 30 20/19 95 34.2* 206
75 30 2.5 10 100 20/16 80 30.1* 175
30 75 10 10 30 20/20 100 25.9* 78.8
30 75 2.5 30 30 20/20 100 28.9* 121
30 75 2.5 10 100 20/16 80 37.7* 298
30 30 10 30 30 20/15 75 40.9* 532
30 30 10 10 100 20/17 85 42.4* 258
30 30 2.5 30 100 20/15 75 47.1* 209
75 75 10 10 30 20/16 80 29.4* 114
75 75 2.5 30 30 20/20 100 29.5* 101
75 75 2.5 10 100 20/14 70 31.6* 95.8
75 30 10 30 30 20/18 90 50.4* 452
75 30 10 10 100 20/17 85 44.3* 282
30 75 10 30 30 20/19 95 39.0* 256
30 75 10 10 100 20/18 90 32.3* 75.0
30 30 10 30 100 20/14 70 57.8* 363
75 30 2.5 30 100 20/17 85 45.4* 226
30 75 2.5 30 100 20/19 95 39.2* 176
75 75 10 30 30 20/14 70 45.7* 110
75 75 10 10 100 20/18 90 36.6* 102
75 30 10 30 100 20/17 85 48.9* 481
75 75 2.5 30 100 20/16 80 47.8* 161
30 75 10 30 100 20/17 85 44.8* 341
75 75 10 30 100 20/14 70 63.8* 393
75 0 0 0 0 10/7 70 7.1* 12.9
0 75 0 0 0 10/10 100 4.1* 1.21
0 0 10 0 0 11/11 100 22.9* 70.6
0 0 0 30 0 10/10 100 13.5* 49
0 0 0 0 100 10/9 90 23* 106
ob 0 0 0 0 20/19 95 0.32 0.36
aMice were treated with each mixture dissolved in tricaprylin by single ip injection (0.2ml) and tumors scored 8 months later. Each group except the tricaprylin control exhib-
ited a 100% tumor incidence. bTricaprylin vehicle control. *Significantly different at p<0.01 from the tricaprylin control by the Bonferroni multiple comparison test after a
square roottransformation of each data point.
matrix of 1001 equations was constructed
representing the dose and response data
from each of the 1001 mice tested. This
regression matrix included data from the
32 quintary mixture groups, the individual
PAH dose-response data, and the indicator
controls. Multiple linear regression
techniques solved this matrix ofequations
and gave estimated parameters, 95%
confidence intervals, and their associated p
values (Table 3). The estimated scale para-
meter, P, was 2.13. The goodness offit of
the model was assessed via the scaled
deviance compared to a chi-square distri-
bution and was determined to be adequate
(p<0.05). The test for the significance of
each model parameter was based on a
comparison of the likelihood values with
the full model and the model excluding the
parameter under study. The p value is
derived from comparing the likelihood
ratio test to a chi-square distribution with
one degree offreedom.
This model produced statistically
significant values for 16 parameters (Table
3). All of the linear terms were highly
significant (p< 0.001). Furthermore, 10 of
the interaction terms were significantly
different from zero at the 5% significance
level. The five significant binary interac-
tion terms were all negative, giving less
than additive interactions: P133 (B[a]P-
DBA), 315 (B[a]P-CPP), 1323 (B[b]F-
DBA), P34 (DBA-5MC), and P35 (DBA-
CPP) (Table 3). Four significant ternary
terms were positive, giving greater than
additive interactions: P1134 (B[a]P-
DBA-5MC), 13135 (B[a]P-DBA-CPP),
13234 (B[b]F-DBA-5MC), and P345 (DBA-
5MC-CPP). One quaternary term was
statistically significant and negative: P1345
(B[a]P-DBA-5MC-CPP).
AdditivityCalculatedfrom
theResponseSurfaceModel
Following the definition of additivity as
given by Berenbaum (11) and the logic of
Carter et al. (12), the model in Equation
1 was reparameterized under the hypo-
thesis ofadditivity (i.e., all ofthe interac-
tion terms were removed) by including
only the intercept and linear terms (i.e.,
Po, 1fil, P2' 13,13f,P5). A likelihood ratio
test was used to test the hypothesis of
additivity by comparing the likelihood of
the constrained model (no interaction
parameters) to the full model, a global test
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Figure 1. Correlation between observed lung adeno-
mas per mouse and expected lung adenomas per
mouse after treatment of male strain A/J mice with
quintary mixtures of polycyclic aromatic hydrocarbons.
The data points represent the mean responses for each
of the 32 quintary mixtures. The calculation of the
expected additive responses for each PAH mixture was
performed by summing the individual responses for
each PAH within each mixture group based on the indi-
vidual PAH dose-response studies in Table 1 and ana-
lyzed as described in Nesnow et al. (20). The
responses for individual PAHs (PAH, dose in milligrams
per kilogram, lung adenomas per mouse): B[a]P, 30,
2.11; B[a]P, 75, 8.14; B[b]F, 30, 1.17; B[b]F, 75, 3.44;
DBA, 2.5, 2.9; DBA, 10, 32.2; 5MC, 10, 1.75; 5MC, 30,
13.2; CPP, 30, 1.53; and CPP, 100, 32.2. The line repre-
sents the expected relationship if the data fit additivity.
* statistically significant difference (p<0.05) between
the observed and expected additive responses based
on the Students-Newman-Keuls multiple comparison
test. a no statistically significant difference between
the observed and expected additive responses.
16,000 -
o 15,000-
0
14,000-
13,000-
0.1 0.2 0.3 0.4 0.5 0.6 0.7
Power parameter
Figure 2. Plot of the log likelihood value versus the
power parametergiven in Equation 1. The full model in
Equation 1 was fit for each value of the power parame-
ter. The peak value of the plot indicates the maximum
likelihood estimate forthe power parameter.
for additivity. Departure from additivity
was found (p< 0.001). A comparison of
the additive responses derived from the
constrained model (no interaction para-
meters) indicated close agreement with
the additive responses obtained from the
sum ofthe individual PAH dose responses
from Table 1 (data not shown).
Prediction ofIndividual
Dose-ResponseCurves
To test the model and model parameters,
predictions for the dose-response rela-
tionships for each of the five PAHs were
calculated. Individual dose-response
curves were generated with the model
parameters (1o, PI, f2, P3, P4, 65) found
in Table 3 and compared to the observed
data found in Table 1 (Figure 3). There
was excellent agreement between the two
data sets. The dose-response data for each
of the individual PAHs (Table 1), alth-
ough used in combination with the mix-
ture tumor data to derive the model
parameters, represent less than 15% ofthe
total data set and therefore were not
expected to dominate these predictions.
PredictionbytheResponseSurface
ModeloftheTumorigenicity
ofthe QuintaryMies
Using Equation 1 and the parameters found
in Table 3, the predicted response for each
quintary mixture was estimated and com-
pared to the observed responses (Table 2)
for each ofthe 32 quintary mixture groups
(Figure 4). Even though only 10 ofthe pos-
sible 26 interaction parameters were signifi-
cant (p<0.05), the model and model
parameters predicted the observed responses
to a high degree. The correlation coefficient
R2 was 0.979, the slope of the line was
0.996, and they-intercept was 0.167. The
95% prediction intervals encompassed
almost all ofthe data points.
EffectofPyrene on One
QuintaryMixture
An additional group of mice was treated
with a mixture containing the following
PAHs (milligrams/kilogram): B[a]P, 30;
B[b]F, 30; DBA, 2.5; 5MC, 30; CPP,
100; and pyrene, 100, using the same
experimental protocol as described for the
32 quintary PAH groups. Pyrene was not
Table 3. Estimated model parametersforthe square root linear response surface model based on Equation 1.a
Parameter Estimate 95% Cl pvalue
Bo 0.437 0.276, 0.597 <0.001
p1 (B[a]P) 0.0271 0.0249, 0.0294 <0.001
/32(B[b]F) 0.0125 0.0107, 0.0149 <0.001
/3 (DBA) 0.497 0.456, 0.538 <0.001
/34 (5MC) 0.0968 0.0915, 0.102 <0.001
P5(CPP) 0.0473 0.0449,0.0497 <0.001
/312 0.317x10-4 0.809
/313 -30.3x10-4 -58.1 x10-4,-2.53x10-4 0.032
/314 1.88x10-4 0.610
/15 -4.67x10-4 -7.20x10-4,-2.14x10-4 <0.001
23 -40.9x10-4 -67.0x10-4,-14.9x10-4 0.002
/24 1.6x10-4 0.657
/25 0.009x10-4 0.943
P34 -179x10-4 -260x10-4,-98.8x10-4 <0.001
P35 --54.3x10-4 -79.6x1O4,-28.9x 10-4 <0.001
P45 -3.94x104 0.290
/3123 22.7x10- 0.531
/3124 -18.6x106 0.064
/3125 -0.04x104 0.991
P/134 196x10-6 3.25x10-,389x10- 0.046
/3135 86.Ox10-6 24.8x10-,147x106 0.006
/3145 3.17x104 0.732
/3234 202x10-6 128x106,391x10- 0.036
/3235 37.5x10- 0.220
/3245 -11.lxlO6 0.220
P345 285x10-6 113x10-,458x106 0.001
/31234 -14.1 x10-7 0.511
/31235 -8.22x10-7 0.218
/31245 2.39x10-7 0.234
/31345 -52.5x10-7 -87.8x10-7, -17.4x10-7 0.003
/32345 -31.7x10-7 0.074
/312345 6.14x10-8 0.082
aThe estimate for 0is 2.13. Values in bold text are statisticallysignificant.
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Figure 3. Observed male strain A/J mouse lung adenoma data for (A) B[a]P and B[b]F, (B) DBA, (C) CPP, and (D)
5MC compared to dose-response curves for each polycyclic aromatic hydrocarbon generated by the response sur-
face model. The curves are from Equation 1 using the dose parameters from Table 3 (i.e., Ao, A, /,P/,3, P4, f5).
The data points represent means ±SD ofobserved lung adenomas/mouse fromTable 1.
Table 4. Influence of pyrene on lung tumorigenicity of a quintary mixture of polycyclic aromatic hydrocarbons in
male strainA/J mice.a
Dose, No. mice Mice with Lung adenomas
Treatment mg/kg treated/scored lung adenomas, % per mouse, mean±SD
Pyrene 200 20/20 40 0.6±0.8*
100 20/20 25 0.4±0.9*
50 20/20 15 0.3±0.8*
10 20/20 30 0.5±0.9*
Five-PAH mixture b 20/15 100 47.1 ±15.6**
Five-PAH mixture+pyrene C 20/12 100 30.5±14**,***
Tricaprylin - 20/19 26 0.32±0.57
&Mice were treated with each mixture dissolved in tricaprylin by single ip injection (0.2 ml) and tumors scored 8
months later. %The doses (milligrams/kilogram) ofthe PAHs were B[a]P, 30; B[b]F, 30; DBA, 2.5; 5MC, 30; and CPP,
100. cThe doses(mg/kg) ofthe PAHs were B[a]P, 30; B[b]F, 30; DBA, 2.5; 5MC, 30; CPP, 100; and pyrene, 100. *Not
statistically different from tricaprylin control (p=0.614). **Statistically different from tricaprylin control (p< 0.001).
***Statistically different from the five-PAH mixture (p=0.007). Values in bold text are statistically significant.
tumorigenic at doses between 10 and 200
mg/kg (Table 4). A similar model to that
described in Equation 1 was used to fit a
subset of the mixture data and the pyrene
data. The subset consisted ofthe tricaprylin
control group, the group exposed to the five
PAHs, the group solely exposed to pyrene,
and the group simultaneously exposed to
the five PAHs and pyrene. Thus the data
consisted of a 2 x2 design and was analyzed
accordingly. The effect of pyrene was not
different from background (p=0.614), the
effect of the five-PAH mixture was to
increase the numbers of lung adenomas
from background (p< 0.001), and the
interaction of the five-PAH mixture and
pyrene was negative and significant
(p= 0.007). Therefore, pyrene exerted a
Observed mean lung adenomas/mouse
Figure 4. Correlation between the observed tumori-
genic responses of male strain A/J mice treated with
quintary mixtures of polycyclic aromatic hydrocarbons
and the predicted responses from the response surface
model. The data points represent the mean responses
for each of the 32 quintary mixtures. R2=0.979;
slope =0.996; yintercept= 0.167. The dashed lines rep-
resent 95% prediction intervals. The predicted
responses were derived using Equation 1 and the para-
meters found in Table 3. Sixteen of the 32 parameters
used in these calculations were significant at p < 0.05.
35% reduction in the lung tumorigenicity
ofthe quintary mixture.
Discussion
Polycyclic aromatic hydrocarbons are
ubiquitous environmental contaminants
found in the air, soil, and water, and in
hazardous wastesites. Since theirdiscovery as
carcinogens in 1915 (27), their toxicologic
effects have been studied intensively. Many
PAHs are carcinogenic in multiple species
(28) and are suspected carcinogens in
humans (29), which also makes them an
important chemical class from a public
health standpoint. The epidemiologic data
on PAH-containing mixtures strongly sug-
gests that they are human respiratory car-
cinogens. The experimental animal data
also point to lung, subcutaneous tissue,
mammary tissue, and liver (in newborn
and juvenile rodents) as targets ofPAHs by
various routes ofadministration (ip, intra-
mammary, intrapleural, oral, inhalation,
dermal, and iv). Because humans are
exposed to mixtures of PAHs, it is impor-
tant to understand the interactions among
PAHs in these mixtures to assess their risk
to humans. Statistical methodology is
available that allows the determination of
specific interactions between groups of tox-
icologic and pharmacologic agents using
response surface methods (12,30,31).
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To determine some of these potential
PAH interactions, a study was constructed
using five environmentally relevant PAHs
administered as quintary mixtures to strain
A/J mice with lung adenoma formation as
the toxicologic outcome. The PAHs
selected were B[a]P, B[b]F, DBA, 5MC,
and CPP, based on their environmental
occurrence, range oftumorigenic activities
(32-37), structural features (methylated vs
nonmethylated, condensed vs linear, alter-
nant vs nonalternant), and a diversity of
routes ofmetabolic activation (38-46).
The strain A/J mouse system is a
medium-term tumorigenesis bioassay
where tumors can be detected and quanti-
tated 8 months after treatment. This
mouse carries a lung cancer susceptibility
gene or genes that have not yet been iden-
tified (18). Studies have shown that lung
adenomas in this mouse will progress to
adenocarcinomas after 18 to 24 months,
with some metastasis. In addition, alveolo-
genic carcinomas in humans are similar in
morphology to adenocarcinomas in mouse
lung (18). Finally, studies have shown that
lung tumors in strain A/J mice produced
by PAHs exhibit high proportions ofKi-ras
mutations with mutation spectra different
from the spontaneous controls (47-50).
From these facts, we conclude that tumor
formation in the strain A/J mouse has
some relevance in the study of human
lung cancer.
The results of these investigations
indicate significant deviations from addi-
tivity that were both greater than additive
and less than additive. The extent ofthese
deviations ranged from +97.4 to -55% of
that expected from additivity. Significant
deviations were observed that were dose
related i.e., lower doses, greater than addi-
tive; higher doses, less than additive.
However, less than additive interactions
dominated under most mixture conditions.
Response surface modeling using multilin-
ear regression techniques identified 6 statis-
tically significant dose parameters and 10
significant interaction parameters of 32
possible parameters. The model and the
estimated model parameters predicted the
observed responses as well as the individual
PAH dose-response curves. In additional
studies we examined the need ofall of the
interaction parameters and found that sig-
nificant fits to the data could not be
obtained with fewer than the full comple-
ment of 26 interaction parameters (data
not shown).
An analysis of the binary carcinogen
interaction literature that encompasses
multiple species, organs, and routes of
administration has identified both greater
than additive and less than additive effects
for PAH-PAH interactions depending on
target tissue species and route of adminis-
tration (4). In single subcutaneous injec-
tion studies in female NMRI mice, Pfeiffer
(37) reported dose-response sarcoma data
with B[a]P, DBA, and mixtures of B[a]P
and DBA at 114 weeks. The authors
found the dose-response curves of the
DBA group and the binary mixtures of
B[a]P and DBA were not statistically dif-
ferent. This suggested a less than additive
interaction between B[a]P and DBA.
Schmahl et al. (51) summarized lifetime
dermal application studies (two applica-
tions/week) of B[a]P and mixtures of
PAHs, including B[a]P, B[b]F, and DBA
in NMRI mice. Significant less than addi-
tive responses from the B[a]P dose
response were noted in the four carcino-
genic PAH mixture group receiving B[a]P,
B[b]F, DBA, and benz[a]anthracene.
Therefore, the studies by Pfeiffer (37) and
Schmahl et al. (51) on the inhibitory
tumorigenic activity of DBA in mouse
skin and subcutaneous tissues are consis-
tent with the inhibitory lung tumorigenic
activity ofDBA with other PAHs, possibly
suggesting competitive inhibition of the
enzymes involved in the metabolic activa-
tion ofthese PAHs.
There are a number of seemingly
conflicting reports on the interactive
effects of PAH, either in binary mixtures
or in combination with complex mixtures
containing PAHs. For example, B[a]P and
CPP exert a greater than additive effect
toward the induction ofmouse skin papil-
lomas (4), whereas this mouse lung study
identified a less than additive interaction.
Similarly, B[a]P and pyrene induce a
greater than additive effect in papilloma
formation in mouse skin tumor initiation
studies (36), whereas pyrene, which
induces neither mouse skin tumors (36)
nor mouse lung tumors in strain A/J mice,
significantly inhibits the lung adenoma
formation ofa quintary mixture of B[a]P,
B[b]F, DBA, 5MC, and CPP. Finally, in
mouse skin tumor coinitiation studies,
cotreatment (initiation) of mice with
B[a]P and cigarette smoke condensate fol-
lowed by 12-O-tetradecanoylphorbol- 13-
acetate promotion produced a greater
than additive effect, whereas similar
studies with B[a]P and diesel exhaust
particulate extracts produced a less than
additive effect (36). Certainly, mixture
composition, target tissues, species, strain,
sex, and route ofadministration must play
a role in the tumor outcome. Moreover,
carcinogenesis is a multistage process that
can involve absorption, distribution,
metabolism, detoxification, elimination,
macromolecular damage, mutation and/or
chromosomal damage, DNA repair,
altered gene expression, cytotoxicity,
tissue injury, cell proliferation, and apop-
tosis. Many of these processes can be
altered by enzyme induction and inhi-
bition (3). Gibb and Chen (52) suggested
that in the multistage model, a multipli-
cative effect oftwo or more carcinogens is
consistent where each carcinogen acts on a
different stage, whereas additivity occurs
when each carcinogen acts on the same
stage. Synergism has also been defined as
occuring when the rate-limiting step in
the generation of a single type of tumor
differs for each of the two interacting
carcinogens (53).
One approach to teasing out the
dominant factors is to examine each
separately. Future studies include examin-
ing quantitative DNA adduct formation,
persistence, and repair over time and
comparing the extent of DNA adducts
formed by the quintary mixtures with the
levels ofadducts expected from additivity
for each of the PAHs. Mixtures of PAHs
enhance and inhibit covalent DNA bind-
ing (54). These studies are currently
in progress.
In conclusion, a response surface
model has identified a number of
PAH-PAH interactions in a quintary
mixture that accurately accounted for all
of the observed responses. The observa-
tion of greater than additive responses
from lower exposures is significant.
However, because the magnitudes ofall of
the interactions were relatively small,
these data suggest that although interac-
tions of PAHs do occur, they are limited
in extent.
DISCLAIMER: This manuscript has
been reviewed by the National Health
and Environmental Effects Research
Laboratory, U.S. EPA, and approved for
publication. Mention of trade names or
commercial products should not be con-
strued as endorsement or recommendation
for use.
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Appendix
g(,u)=x'P [1]
where: ,u=the number oflung adenomas for the nth mouse
g(.) =aspecified monotone function ofthe mean
X' =f/o +PIXI +f2X2 +f3X3 +fI4X4 +f5X5
+1PI2XlX2 +P13xlX3 +fi4xlX4 +f15xlX5 +fl23X2X3 +$324X2X4
+/25x2X5 + 334x3X4 +f35X3x5 + 345X4x5 +fl123x1X2X3
+1PI24xlx2X4 +1fl25xlX2X5 +fl34XlX3X4 +PI135x1X3X5
+f1345X1X4X5 +P234X2x3X4 +fl235X2x3X5 +f245X2X4X5
+f3345x3X4x5 +P234xlx2X3X4 +f31235xlx2x3x5
+f1i245xlX2X4X5 +f1i345xlX3X4X5 + P2345X2X3X4X5
+/12345xlX2x3X4X5
xl=dose ofB[a]P (mg/kg)
x2=dose ofB[b]F (mglkg)
X3=dose ofDBA (mg/kg)
X4=dose of5MC (mg/kg)
X5=dose ofCPP (mg/kg)
fio = unknown parameter associated with the background
number oftumors
3il =unknown parameter associated with the effect of B[a]P
on the number oftumors
P2 =unknown parameter associated with the effect ofB[b]F
on the number oftumors
13 = unknown parameter associated with the effect of DBA
on the number oftumors
, =unknown parameter associated with the effect of 5MC
on the number oftumors
15 =unknown parameter associated with the effect of CPP
on the number oftumors
P12=unknown parameter associated with the interaction of
B[a]P and B[b]F on the number oftumors
P13 =unknown parameter associated with the interaction of
B[a]P and DBA on the number oftumors
1314 = unknown parameter associated with the interaction of
B[a]P and 5MC on the number oftumors
135 = unknown parameter associated with the interaction of
B[a]P and CPP on the number oftumors
1323 =unknown parameter associated with the interaction of
B[b]F and DBA on the number oftumors
1324 =unknown parameter associated with the interaction of
B[b]F and 5MC on the number oftumors
P25 =unknown parameter associated with the interaction of
B[b]F and CPP on the number oftumors
P34= unknown parameter associated with the interaction of
DBA and 5MC on the number oftumors
P35 =unknown parameter associated with the interaction of
DBAand CPP on the number oftumors
P45 =unknown parameter associated with the interaction of
5MC and CPP on the number oftumors
P/123 = unknown parameter associated with the interaction of
B[a]P, B[b]F, and DBA on the number oftumors
/3124 =unknown parameter associated with the interaction of
B[a]P, B[b]F, and 5MC on the number oftumors
P/125 =unknown parameter associated with the interaction of
B[a]P, B[b]F, and CPP on the number oftumors
/3134 =unknown parameter associated with the interaction of
B[a]P, DBA, and 5MC on the number oftumors
P135 = unknown parameter associated with the interaction of
B[a]P, DBA, and CPP on the number oftumors
P145 =unknown parameter associated with the interaction of
B[a]P, 5MC, and CPP on the number oftumors
P234 = unknown parameter associated with the interaction of
B[b]F, DBA, and 5MC on the number oftumors
P235 = unknown parameter associated with the interaction of
B[b]F, DBA, and CPP on the number oftumors
P245 = unknown parameter associated with the interaction of
B[b]F, 5MC, and CPP on the number oftumors
/345 =unknown parameter associated with the interaction of
DBA, 5MC, and CPP on the number oftumors
/31234 =unknown parameter associated with the interaction of
B[a]P, B[b]F, DBA, and 5MC on the number oftumors
P/1235 =unknown parameter associated with the interaction of
B[a]P, B[b]F, DBA, and CPP on the number oftumors
/31245 =unknown parameter associated with the interaction of
B[a]P, B[b]F, 5MC, and CPP on the number oftumors
/31345 = unknown parameter associated with the interaction of
B[a]P, DBA, 5MC, and CPP on the number oftumors
P2345 = unknown parameter associated with the interaction of
B[b]F, DBA, 5MC, and CPP on the number oftumors
/312345 =unknown parameter associated with the interaction of
B[a]P, B[b]F, DBA, 5MC, and CPP on the number of
tumors
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